Skip to main content

Table 2 Geometric mean of EPG for Capillaria spp. at each time point and percent of reduction at each time point

From: Efficacy of milbemycin oxime/afoxolaner chewable tablets (NEXGARD SPECTRA®) against Capillaria aerophila and Capillaria boehmi in naturally infected dogs

  Day 6/-2 Day 28 Day 56
Group 1 120.39 [0–600] 94.04 [0–300] 127.38 [0–1400]
Group 2 164.11 [0–1350] 2.36 [0–100] 0.00 [0–0]
Efficacy (P-value) NA (NS) 97.49% (1.65 × 10−9) 100.00% (2.12 × 10−11)
  1. Group 1: dogs treated with the negative control product NEXGARD®
  2. Group 2: dogs treated with NEXGARD SPECTRA®
  3. NS Not statistically significant. [Minimum–maximum EPG values]